Elevation Wealth Partners
PRCT icon

Elevation Wealth Partners’s Procept Biorobotics PRCT Stock Holding History

Elevation Wealth Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$128 Hold
7
– – ﹤0.01% 1331
2026
Q2 		$159 Hold
7
– – ﹤0.01% 1291
2026
Q1 		$176 Buy
7
+5
+250% +$141 ﹤0.01% 1062
2025
Q4 		$63 Hold
2
– – ﹤0.01% 946
2025
Q3 		$72 Hold
2
– – ﹤0.01% 858
2025
Q2 		$116 Hold
2
– – ﹤0.01% 463
2025
Q1 		$117 Hold
2
– – ﹤0.01% 469
2024
Q4 		$162 Buy
+2
New +$171 ﹤0.01% 470

Other funds holding PRCT

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Bastion Asset Management
Bastion Asset Management Montreal, Canada $229M AUM 5.92% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Elevation Wealth Partners's PRCT Position: Q3 2026 in Review

Elevation Wealth Partners held its Procept Biorobotics (PRCT) position steady in Q3 2026 at 7 shares worth $128. The position accounts for ﹤0.01% of the portfolio, ranked #1331.

Elevation Wealth Partners first reported a position in PRCT in Q4 2024 and has held it in 8 quarters since. The position peaked at $176 in Q1 2026. 89 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Elevation Wealth Partners held 7 shares of Procept Biorobotics worth $128 as of Q3 2026.
  • Elevation Wealth Partners left its Procept Biorobotics share count unchanged in Q3 2026.
  • Procept Biorobotics made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1331 holding.
  • Elevation Wealth Partners first reported a position in Procept Biorobotics in Q4 2024 and has held it in 8 quarters since.
  • Elevation Wealth Partners's Procept Biorobotics position peaked at $176 in Q1 2026.
  • 89 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.